2018, Número 4
<< Anterior Siguiente >>
Ann Hepatol 2018; 17 (4)
Urinary Neutrophil Gelatinase-Associated Lipocalin in Cirrhotic Patients with Acute Kidney Injury
Hamdy HS, El-Ray A, Salaheldin M, Lasheen M, Aboul-Ezz M, Abdel-Moaty AS, Abdel-Rahim A
Idioma: Ingles.
Referencias bibliográficas: 12
Paginas: 624-630
Archivo PDF: 190.01 Kb.
RESUMEN
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
Guerra J, Garenne M, Mohamed MK, Fontanet A. HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat 2012; 19: 560-7.
du Cheyron D, Bouchet B, Parienti JJ, Ramakers M, Charbonneau P. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med 2005; 31: 1693-9.
Garcia-Tsao G, Parikh C and Viola A. Acute kidney injury in cirrhosis. Hepatology 2008; 48: 2064-77.
Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase- Fielitz A. NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54: 1012-24.
Belcher J, Edelstein C, Parikh C. Clinical applications of biomarkers for acute kidney injury. Am J Kidney Dis 2011; 57: 930-40.
Makris K, Markou N, Evodia E, Dimopoulou E, Drakopoulos I, Ntetsika K, Rizos D, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clinical Chemistry and Laboratory Medicine 2009; 47: 79-82.
Verna EC, Brown RS, Farrand E, Pichardo EM, Forster CS, Sola-Del Valle DA, Adkins SH, et al. Urinary Neutrophil Gelatinase- Associated Lipocalin Predicts Mortality and Identifies Acute Kidney Injury in Cirrhosis. Dig Dis Sci 2012; 57: 2362-70.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007; 56: 131018.
Belcher JM, Sanyal AJ, Peixoto AJ, Perazella MA, Lim J, Thiessen-Philbrook H, Ansari N, et al. Kidney Biomarkers and Differential Diagnosis of Patients With Cirrhosis and Acute Kidney Injury. Hepatology 2014; 60: 622-32.
Qasem AA, Farag SE, Hamed E, EmaraM, Bihery A and Pasha H. Urinary Biomarkers of Acute Kidney Injury in Patients with Liver Cirrhosis. ISRN Nephrology 2014; 68: 132-6.
Treeprasertsuk S, Wongkarnjana A, Jaruvongvanich V, Sallapant S, Tiranathanagul K, Komolmit P, Tangkijvanich P. Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions. BMC Gastroenterology 2015; 15: 140.